duloxetine hydrochloride has been researched along with Complications, Pregnancy in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Bateman, BT; Bessette, LG; Hernandez-Diaz, S; Huybrechts, KF; Levin, R; Li, H; Mogun, H; Motsko, S; Pawar, A; Scantamburlo Fernandes, MF; Upadhyaya, HP | 1 |
Fusco, ML; Gentile, S | 1 |
Cheng, Y; Dowsett, SA; Elpers, J; Hoog, SL | 1 |
Amital, D; Amital, H; Arnson, Y; Milstein, R | 1 |
Andrade, C | 1 |
Bellantuono, C; Mandarelli, G; Martini, MG; Nardi, B; Vargas, M | 1 |
2 review(s) available for duloxetine hydrochloride and Complications, Pregnancy
Article | Year |
---|---|
Managing fibromyalgia syndrome in pregnancy no bridges between USA and EU.
Topics: Anti-Anxiety Agents; Duloxetine Hydrochloride; Europe; Female; Fibromyalgia; Humans; Milnacipran; Pregabalin; Pregnancy; Pregnancy Complications; Risk Assessment; Serotonin and Noradrenaline Reuptake Inhibitors; United States | 2019 |
The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review.
Topics: Abnormalities, Drug-Induced; Breast Feeding; Duloxetine Hydrochloride; Female; Humans; Infant, Newborn; Lactation; Pregnancy; Pregnancy Complications; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2015 |
4 other study(ies) available for duloxetine hydrochloride and Complications, Pregnancy
Article | Year |
---|---|
Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Cohort Studies; Duloxetine Hydrochloride; Female; Heart Defects, Congenital; Humans; Infant, Small for Gestational Age; Middle Aged; Postpartum Hemorrhage; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Premature Birth; Prenatal Exposure Delayed Effects; Serotonin and Noradrenaline Reuptake Inhibitors; United States; Young Adult | 2020 |
Duloxetine and pregnancy outcomes: safety surveillance findings.
Topics: Abortion, Spontaneous; Adult; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Depressive Disorder, Major; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Female; Humans; Infant; Infant, Newborn; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Thiophenes; United States; United States Food and Drug Administration | 2013 |
Retraumatization eliciting the presentation of fibromyalgia.
Topics: Adult; Analgesics; Antidepressive Agents; Cannabinoids; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Pregabalin; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Stress, Psychological; Thiophenes; Uterine Rupture | 2013 |
The safety of duloxetine during pregnancy and lactation.
Topics: Antidepressive Agents; Depression; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Infant; Lactation; Milk, Human; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Thiophenes | 2014 |